Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT02280850
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Shaanxi Buchang Pharmaceutical Co., Ltd
- Registry
-
NCT02280850
-
- Other papers using this trial's data
- Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02280850. Randomized; quadruple masking; primary purpose treatment. Start 2014-10 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina
- Condition
- Angina, Stable
- Intervention (Drug)
- Guanxin Shutong Capsule
- Intervention (Drug)
- Placebo Capsule
- Intervention (Drug)
- nitroglycerine
- Lead sponsor
- Shaanxi Buchang Pharmaceutical Co., Ltd
Record details
- Record id
cardio:ct-nct02280850- Content hash
24b24879eb96cf68094c6224bbd80b2bd6f7883d982f67ea19de97d64832abbb